Effect of type I interferon(s) on cell viability and apoptosis in primary human thyrocyte cultures

Thyroid

Volumn 19, Issue 2, 2009, Pages 149-155

  Caraccio, Nadia ^a   Cuccato, Sabina ^a   Pratesi, Federico ^a   Dardano, Angela ^a   Ursino, Silvia ^a   Chimenti, Daniele ^a   Boldrini, Laura ^a   Materazzi, Gabriele ^a   Migliorini, Paola ^a   Monzani, Fabio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; FAS ANTIGEN; FAS LIGAND; MESSENGER RNA; PROTEIN BCL 2; THYROTROPIN;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DIPLOIDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MONOLAYER CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CELL;

ANTIGENS, CD95; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; DOWN-REGULATION; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE I; INTERFERON-ALPHA; INTERFERON-BETA; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; THYROID DISEASES; THYROID GLAND; THYROTROPIN;

EID: 59649089769     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2008.0290     Document Type: Article

References (32)

1. Baron S, Tyring SK, Fleischmann WR Jr., Coppenhaver DH, Niesel DW, Klimpel GR, Stanton GJ, Hughes TK 1991 The interferons. Mechanisms of action and clinical applications. JAMA 266:1375-1383.
2. Monzani F, Caraccio N, Dardano A, Ferrannini E 2004 Thyroid autoimmunity and dysfunction associated with type I interferon therapy. Clin Exp Med 3:199-210.
3. Vial T, Descotes J 1995 Immune-mediated side-effects of cytokines in humans. Toxicology 105:31-57.
4. 125I incorporation and thyroid hormone release by human thyroid follicles in vitro. J Clin Endocrinol Metab 77:1439-1441.
5. Caraccio N, Giannini R, Cuccato S, Faviana P, Berti P, Galleri D, Dardano A, Basolo F, Ferrannini E, Monzani F 2005 Type I interferons modulate the expression of thyroid peroxidase, sodium/iodide symporter, and thyroglobulin genes in primary human thyrocyte cultures. J Clin Endocrinol Metab 90:1156-1162.
6. Selzer E, Wilfing A, Sexl V, Freissmuth M 1994 Effects of type I-interferons on human thyroid epithelial cells derived from normal and tumour tissue. Naunyn Schmiedebergs Arch Pharmacol 350:322-328.
7. Yamazaki K, Suzuki K, Yamada E, Yamada T, Takeshita F, Matsumoto M, Mitsuhashi T, Obara T, Takano K, Sato K 2007 Suppression of iodide uptake and thyroid hormone synthesis with stimulation of the type I interferon system by double-stranded ribonucleic acid in cultured human thyroid follicles. Endocrinology 148:3226-3235.
8. Eguchi K 2001 Apoptosis in autoimmune diseases. Intern Med 40:275-284.
9. Mezosi E, Wang SH, Utsugi S, Bajnok L, Bretz JD, Gauger PG, Thompson NW, Baker JR Jr. 2005 Induction and regulation of Fas-mediated apoptosis in human thyroid epithelial cells. Mol Endocrinol 19:804-811.
10. Giordano C, Stassi G, De Maria R, Todaro M, Richiusa P, Papoff G, Ruberti G, Bagnasco M, Testi R, Galluzzo A 1997 Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275:960-963.
11. Bossowski A, Czarnocka B, Bardadin K, Urban M, Niedziela M, Dadan J 2008 Expression of Bcl-2 family proteins in thyrocytes from young patients with immune and nonimmune thyroid diseases. Horm Res 70:155-164.
12. Jacobson MD, Burne JF, Raff MC 1994 Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J 13:1899-1910.
13. Brunner T, Mogil RJ, LaFace D, Yoo N, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR 1995 Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441-444.
14. Stellar H 1995 Mechanisms and genes of cellular suicide. Science 267:1445-1449.
15. Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Kawabe Y, Ishikawa N, Ito K, Nagataki S 1996 Thyroid-stimulating hormone inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro. Endocrinology 137:3163-3169.
16. Chawla-Sarkar M, Lindner DJ, Liu YF, Williams BR, Sen GC, Silverman RH, Borden EC 2003 Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8:237-249.
17. Mosmann T 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
18. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C 1991 A rapid and simple method for measuring thymocytes apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279.
19. Vial T, Descotes J 1994 Clinical toxicity of the interferons. Drug Saf 10:115-150.
20. Dusheiko G 1997 Side effects of interferon in chronic hepatitis C. Hepatology 26:112S-121S.
21. Dumoulin FL, Leifeld L, Sauerbruch T, Spengler U 1999 Autoimmunity induced by interferon-α therapy for chronic viral hepatitis. Biomed Pharmacother 53:242-254.
22. Vladutiu AO, Rose NR 1971 Autoimmune murine thyroiditis relation to histocompatibility (H-2) type. Science 174:1137-1139.
23. Weigle WO 1980 Analysis of autoimmunity through experimental models of thyroiditis and allergic encephalomyelitis. Adv Immunol 30:159-273.
24. Kotani T, Aratake Y, Hirai K, Fukazawa Y, Sato H, Ohtaki S 1995 Apoptosis in thyroid tissue from patients with Hashimoto's thyroiditis. Autoimmunity 20:231-236.
25. Tanimoto C, Hirakawa S, Kawasaki H, Hayakawa N, Ota Z 1995 Apoptosis in thyroid diseases: a histochemical study. Endocr J 42:193-201.
26. Hammond LJ, Lowdell MW, Cerrano PG, Goode AW, Bottazzo GF, Mirakian R 1997 Analysis of apoptosis in relation to tissue destruction associated with Hashimoto's autoimmune thyroiditis. J Pathol 182:138-144.
27. Tamura M, Kimura H, Koji T, Tominaga T, Ashizawa K, Kiriyama T, Yokoyama N, Yoshimura T, Eguchi K, Nakane PK, Nagataki S 1998 Role of apoptosis of thyrocytes in a rat model of goiter. A possible involvement of Fas system. Endocrinology 139:3646-3653.
28. Mitsiades N, Poulaki V, Kotoula V, Mastorakos G, Tseleni-Balafouta S, Koutras DA, Tsokos M 1998 Fas/Fas ligand upregulation and Bcl-2 downregulation may be significant in the pathogenesis of Hashimoto's thyroiditis. J Clin Endocrinol Metab 83:2199-2203.
29. Walczak H, Krammer PH 2000 The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res 256:58-66.
30. Bretz JD, Arscott PL, Myc A, Baker JR Jr. 1999 Inflammatory cytokine regulation of Fas-mediated apoptosis in thyroid follicular cells. J Biol Chem 274:25433-25438.
31. Valente WA, Vitti P, Kohn LD, Brandi ML, Rotella CM, Toccafondi R, Tramontano D, Aloj SM, Ambesi-Impiombato FS 1983 The relationship of growth and adenylate cyclase activity in cultured thyroid cells: separate bioeffects of thyrotropin. Endocrinology 112:71-79.
32. Chawla-Sarkar M, Leaman DW, Borden EC 2001 Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines. Clin Cancer Res 7:1821-1831.